Evidence map›Paper›PMID 41321563›Full record

ArticleFrontiers in genetics2025

Case Report: Identification and functional characterization of a novel heterozygous splice-donor (c.647+1G>A) site mutation in the

Ke Cao, Xiaojuan Luo, Lianlian Liu, Xiaoning Mao, Ruping Liu, Yunsheng Chen, Santasree Banerjee

Abstract readCase Reports
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ke Cao *Department of Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Xiaojuan Luo *Department of Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Lianlian LiuDepartment of Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Xiaoning MaoDepartment of Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Ruping LiuDepartment of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.
Yunsheng ChenDepartment of Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Santasree BanerjeeDepartment of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Hereditary spherocytosis (HS) is an inherited disorder characterized by spherical erythrocytes and abnormalities of several erythrocyte membrane proteins with extreme genotypic and phenotypic heterogeneity. HS patients were clinically diagnosed by the presence of spherical erythrocytes on the peripheral blood smear, hemolytic anemia, jaundice, and splenomegaly, with or without cholelithiasis or gallstones. To date, mutations of five genes ( Methods: In this study, we investigated a 10-year-old Chinese girl clinically diagnosed with HS and neonatal hemolytic anemia. The proband's mother was also identified with HS and hemolytic anemia, but the proband's father was phenotypically normal. We performed a standard G-banding karyotype to identify structural abnormalities of chromosomes in this proband. Then, we performed whole-exome sequencing and Sanger sequencing to identify the disease-causing variants in this proband. Finally, we functionally characterized the identified novel variant by performing reverse transcription polymerase chain reaction, cDNA sequencing, quantitative real-time polymerase chain reaction (PCR), and Western blot. Results: Whole exome sequencing identified a heterozygous novel splice-donor-site (c.647 + 1G>A) mutation in the Conclusion: Our present study highlighted the significance of whole-exome sequencing as the most promising path to genetic molecular diagnosis for patients with HS.

Indexed as

hemolytic anemiahereditary spherocytosisnovel mutationsplice-donor site mutationSPTB gene

Identifiers

PMID41321563
PMCPMC12659992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.